Long-term outcome after treatment of hydrocephalus in children

Area of Science:

• Pediatric Neurosurgery
• Medical Device Outcomes
• Clinical Research

Background:

• Hydrocephalus is a common neurological condition in children requiring surgical intervention.
• Ventriculoperitoneal shunts (VPS) and endoscopic third ventriculostomy (ETV) are primary treatment modalities.
• Long-term outcome data and risk factors for treatment failure are crucial for optimizing pediatric care.

Purpose of the Study:

• To report long-term outcomes of hydrocephalus treatment in children.
• To identify specific risk factors associated with ventriculoperitoneal shunt (VPS) failure.
• To inform clinical practice and improve patient management strategies.

Main Methods:

• Retrospective review of 98 pediatric patients undergoing ETV or VPS between 2001-2005.
• Prospective data collection on patient demographics, hydrocephalus etiology, and surgical details.
• Univariate Cox proportional hazards regression analysis to determine risk factors for VPS failure over a mean follow-up of 4.7 years.

Main Results:

• Treatment failure rates exceeded 50% for both ETV (55%) and VPS (58%).
• Significant risk factors for VPS failure included prematurity (HR: 2.05), concomitant procedures (HR: 2.07), and prolonged surgery duration (HR: 1.23).
• Factors such as sex, surgeon experience, and time of day did not significantly impact VPS failure rates.

Conclusions:

• Both ETV and VPS demonstrate high failure rates in pediatric hydrocephalus treatment.
• Prematurity and the need for concomitant surgical procedures are significant predictors of VPS failure.
• Further research into mitigating these risk factors is warranted to improve long-term outcomes.